[Treatment of Graves-Basedow disease].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002231:Carbimazole / Q000627:therapeutic use; D005260:Female; D006111:Graves Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007455:Iodine / Q000627:therapeutic use; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D011247:Pregnancy; D011441:Propylthiouracil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D007457:Iodine Radioisotopes; D016651:Lithium Carbonate; D008713:Methimazole; D011441:Propylthiouracil; D002231:Carbimazole; D007455:Iodine; D008094:Lithium
Tratamiento de la enfermedad de Graves-Basedow.